This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dowsett, M. Articles by Smith, I. E. Search for Related Content PubMed Articles by Dowsett, M. Articles by Smith, I. E. Related Articles Related Correspondence

In Reply:

Royal Marsden Hospital, London, United Kingdom

We thank Dr Goodson and colleagues for highlighting our inadvertently incorrect citation of work conducted on the in vivo use of bromodeoxyuridine for assessing the proliferation of breast cancer cells.

We are also pleased to note that they concur with our view that Ki67 is a readily assessed marker of proliferation well-suited to widespread use.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

Related Correspondence

• Ki-67 Correlates With In Vivo Bromodeoxyuridine Labeling Index in Operable Breast Cancer
  William H. Goodson, Dan H. Moore, and Frederick M. Waldman
  JCO 2006 24: 3809 [Full Text]

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dowsett, M. Articles by Smith, I. E. Search for Related Content PubMed Articles by Dowsett, M. Articles by Smith, I. E. Related Articles Related Correspondence